Egor Matnurov explains immunogenic cell death – The Babak Lab
Maria Babak, Assistant Professor at City University of Hong Kong, shared a post by on LinkedIn:
“One of the research directions of our group is the development of novel therapeutic agents capable of activating immune system in cancer patients. These agents are called ICD inducers. We will dedicate this week to the overview of the recent findings in the field of metal-based ICD inducers. Stay tuned for our monthly newsletter to know more about our own ICD-inducing drug candidates.”
Quoting
“Have your ever heard of immunogenic cell death (ICD)? Our PhD student Egor Matnurov will explain it to you in his video.
ICD-inducing agents can trigger localized cell death and induce an immune response to potentially overcome metastatic and relapsing tumors.
Do metal complexes, based on platinum, ruthenium, irhidium, have clinical potential as ICD-inducing therapeutic agents? If you want to know more about it, watch our video and read this review.”
Source: Maria Babak/LinkedIn and
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023